PF-Atlas › Drugs › Inhaled mannitol

Inhaled mannitol

Idiopathic Pulmonary Fibrosis · ANZCTR

Clinical trials
5
Mechanism
ANZCTR
Developer
Syntara

Overview

Inhaled mannitol is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis, acting via anzctr. It appears in 5 tracked IPF clinical trials.

Inhaled mannitol clinical trials

NCT00669331 (Phase 3)NCT02134353 (Phase 3)NCT00455130 (Phase 2)NCT00630812 (Phase 3)NCT01883531 (Phase 2)

Explore related

ANZCTRAll trialsResearch
Medical disclaimer. This page summarizes research about Inhaled mannitol for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.